Zensun Shanghai Science and Technology Ltd.

Shanghai, China

Zensun Shanghai Science and Technology Ltd.

Shanghai, China
SEARCH FILTERS
Time filter
Source Type

Patent
Zensun Shanghai Science and Technology Co. | Date: 2017-08-02

Disclosed are uses of neuregulin in the preparation of medicines for preventing, treating or delaying ventricular arrhythmia of a human being, and pharmaceutical preparations that comprise the neuregulin and are used for preventing, treating or delaying the ventricular arrhythmia.


Patent
Zensun Shanghai Science and Technology Ltd | Date: 2017-10-04

A method for controlling an insulin injection pump, a related control unit (200), and an injection pump (300). The control unit (200) comprises: an expected plasma insulin concentration value acquiring module (202), a current subcutaneous and interstitial insulin concentration value acquiring module (201), a supposed injection value acquiring module (203), an injection instruction sending module (204), and a counting module (205). The injection pump comprises a pump body and the control unit (200), and the control unit (200) is disposed in the pump body.


Patent
Zensun Shanghai Science and Technology Ltd | Date: 2014-12-10

The disclosure provides a composition for arresting or inhibiting cell growth comprising one or more compounds, in particular antibodies, which prevent or reduce ErbB-2/ErbB-3 heterodimer formation in a cell.


Patent
Zensun Shanghai Science and Technology Ltd | Date: 2014-05-14

The present invention relates to an isolated polypeptide comprising an amino acid sequence having at least 70% identity to the amino acid sequence of SEQ ID NO:2 or to the amino acid sequence of SEQ ID NO:25; or encoding a polypeptide comprising the amino acid sequence of SEQ ID NO: 2 or the amino acid sequence of SEQ ID NO: 25, wherein the polypeptide is capable of phosphorylating myosin light chain. The present invention also relates to an isolated nucleic acid encoding said polypeptide; a composition and a kit comprising the polypeptide or the nucleic acid; a vector comprising the isolated nucleic acid; an isolated host cell comprising the nucleic acid or the vector; an antibody that specifically binds to the polypeptide of the present invention; and a transgenic non-human animal which expresses the nucleic acid of the present invention. The invention further relates to a method of detecting the presence of a nucleic acid of the present invention; and a method of producing a neukinase polypeptide of the present invention.


Patent
Zensun Shanghai Science And Technology Ltd. | Date: 2016-04-12

The present invention provides polypeptide variants of neuregulin-1 (NRG-1) that have enhanced or decreased binding affinity to ErbB3 and/or ErbB4. The invention also provides methods of screening and producing polypeptide variants of NRG-1 and methods of using polypeptide variants of NRG-1 for treating diseases.


Patent
Zensun Shanghai Science and Technology Ltd | Date: 2014-02-12

A brush head component connection system, applied in a personal care utensil, comprises: a brush head component and a motor bracket (11) mounted on a personal care utensil casing (13), a motor (10) disposed in the motor bracket (11), and a seal ring (12) located between the motor bracket (11) and the personal care utensil casing (13). A driving shaft of the motor (10) is disposed in holes at the center of the bottoms of the motor bracket (11), the personal care utensil casing (13) and the seal ring (12), and has an end connected to one end of an eccentric shaft (14). The other end of the eccentric shaft (14) deviates from the central position and is connected to the driving shaft connected onto the brush head component. In the brush head component connection system, the motor (10) is connected to the brush head component only through simple components such as the eccentric shaft (14) and the driving shaft, and the motor (40) drives the eccentric shaft to rotate through rotation of the driving shaft, so as to drive the brush head component to rotate; therefore, the energy consumption is low.


Patent
Zensun Shanghai Science and Technology Ltd | Date: 2015-09-16

The invention provides Neuregulin or a functional fragment thereof for use in a method of preventing, treating or delaying heart failure or preventing cardiac hypertrophy in a mammal, wherein the method comprises releasing Neuregulin to the mammal over a period of 4 hours or longer per day by extended release means such as an osmotic pump, a syringe pump, packaging into a liposome or microsphere or coupling to a polymer.


Patent
Zensun Shanghai Science and Technology Ltd | Date: 2013-06-26

The present invention relates to a combination, which combination comprises an effective amount of a neuregulin protein, or a functional fragment thereof, or a nucleic acid encoding a neuregulin protein, or a functional fragment thereof, or an agent that enhances production and/or function of said neuregulin, and an effective amount of a prophylactic or therapeutic agent for myocardial infarction. The present invention also relates to a composition for use in a method of preventing, treating or delaying myocardial infarction in a mammal, comprising an effective amount of a neuregulin protein, or a functional fragment thereof, or a nucleic acid encoding a neuregulin protein, or a functional fragment thereof, or an agent that enhances production and/or function of said neuregulin.


Patent
Zensun Shanghai Science and Technology Ltd | Date: 2014-12-03

The present invention relates to a neuregulin peptide consisting essentially of or consisting of the amino acid sequence selected from the group consisting of SEQ ID NO:9, SEQ ID NO:3, SEQ ID NO:7 and SEQ ID NO:5 as specified herein. The present invention further relates to a pharmaceutical composition comprising the said neuregulin peptide and a pharmaceutically acceptable carrier, excipient, or diluent. The present invention also relates to the said neuregulin peptide for use in a method of treating heart failure in a subject.


Patent
Zensun Shanghai Science and Technology Ltd | Date: 2014-10-01

Disclosed is a drive system of a syringe pump, comprising: an outer sleeve (11) having an inner wall provided with a resistive sheet slot and a conductive sheet slot, both of which slot extending axially; a resistive sheet (12) provided in the resistive sheet slot and a conductive sheet (13) provided in the conductive sheet slot; an injection pushrod (14) slidably provided in the outer sleeve (11), wherein a hermetic seal is maintained between the injection pushrod (14) and the inner wall of the outer sleeve (11), and a cavity having an opening is provided on the injection pushrod (14), with the opening of the cavity being provided at a tail end of the injection pushrod (14); an elastic conductive contact sheet (15) fixedly provided on the injection pushrod (14), with one end of the elastic conductive contact sheet (15) being in contact with the conductive sheet (13) and the other end being in contact with the resistive sheet (12); and a drive device provided in the cavity and driving the injection pushrod (14) to move forth and back. The drive system can ensure the accuracy of administration.

Loading Zensun Shanghai Science and Technology Ltd. collaborators
Loading Zensun Shanghai Science and Technology Ltd. collaborators